Sponsor

Intensity Therapeutics Inc.

United States 1 Enterprise Drive Suite 430, 06484-4779, United States

About the sponsor

Research activity is centered on metastatic soft tissue sarcomas, with attention to treatment options for advanced disease in adult patients.

Liposarcoma subtypes
Undifferentiated pleomorphic sarcoma
Leiomyosarcoma

The sponsor’s clinical focus includes difficult-to-treat sarcoma populations with unresectable or metastatic disease.

About Specializations

Intensity Therapeutics Inc. runs clinical trials in conditions such as Leiomyosarcoma, Malignant fibrous histiocytoma, Myxoid liposarcoma, Dedifferentiated liposarcoma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Leiomyosarcoma+5

Not yet recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of INT230-6 (Vinblastine Sulfate, Cisplatin) for Adults with Metastatic Soft Tissue Sarcomas

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:Intensity Therapeutics Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →